Recently, Waters shared the latest innovations in gene therapy analytical technology with the scientific community at ASGCT 2025. Waters and our Lexeo collaborators led a scientific presentation sharing:
This talk covered the characterization of megadalton-sized biologics, such as lipid nanoparticle mRNA, plasmids, capsids, and viral vectors, which are vital for cell and gene therapy development and testing. SEC is highlighted as a key method for separating these complex modalities, with innovations in SEC column technology enhancing resolution and reducing non-specific interactions. CDMS, particularly in compact benchtop systems, provides rapid and precise characterization of biologics, including detailed analysis of AAV vectors.